Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Surg Endosc ; 21(1): 5-10, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17111280

RESUMEN

BACKGROUND: The Minimally Invasive Surgical Trainer-Virtual Reality (MIST-VR) has been well validated as a training device for laparoscopic skills. It has been demonstrated that training to a level of proficiency on the simulator significantly improves operating room performance of laparoscopic cholecystectomy. The purpose of this project was to obtain a national standard of proficiency using the MIST-VR based on the performance of experienced laparoscopic surgeons. METHODS: Surgeons attending the Society of American Gastrointestinal Endoscopic Surgeons (SAGES) 2004 Annual Scientific Meeting who had performed more than 100 laparoscopic procedures volunteered to participate. All the subjects completed a demographic questionnaire assessing laparoscopic and MIST-VR experience in the learning center of the SAGES 2004 meeting. Each subject performed two consecutive trials of the MIST-VR Core Skills 1 program at the medium setting. Each trial involved six basic tasks of increasing difficulty: acquire place (AP), transfer place (TP), traversal (TV), withdrawal insert (WI), diathermy task (DT), and manipulate diathermy (MD). Trial 1 was considered a "warm-up," and trial 2 functioned as the test trial proper. Subject performance was scored for time, errors, and economy of instrument movement for each task, and a cumulative total score was calculated. RESULTS: Trial 2 data are expressed as mean time in seconds in Table 2. CONCLUSION: Proficiency levels for laparoscopic skills have now been established on a national scale by experienced laparoscopic surgeons using the MIST-VR simulator. Residency programs, training centers, and practicing surgeons can now use these data as guidelines for performance criterion during MIST-VR skills training.


Asunto(s)
Competencia Clínica , Simulación por Computador , Evaluación Educacional , Laparoscopía , Procedimientos Quirúrgicos Mínimamente Invasivos/educación , Interfaz Usuario-Computador , Adulto , Humanos , Persona de Mediana Edad , Encuestas y Cuestionarios
2.
Hernia ; 9(4): 358-62, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-16082500

RESUMEN

BACKGROUND: One criticism of laparoscopic ventral hernia repair (LVH) is that the rectus muscles are not re-approximated to the midline, and the effect of LVH repair on the fascial edges is unclear. Progressive migration of the fascial edges toward the midline has been observed anecdotally, but objective evidence remains limited. The purpose of this study is to observe the effect of LVH repair on the rectus abdominus fascia. METHODS: Patients undergoing LVH repair with defects > 10 cm in horizontal diameter were identified prospectively and enrolled. All were repaired laparoscopically with intraperitoneal placement of mesh (DualMesh, W.L. Gore and Associates) using a standard approach. Radio-opaque clips were placed at the fascial edges intraoperatively to mark the defect, and plain abdominal films were taken postoperatively (Time 1) to establish the initial distance between clips (measured in cm). A subsequent follow-up film was taken (Time 2), and the difference in clip distance per patient was recorded. Results were analyzed using a chi-squared test. RESULTS: Twelve patients qualified for analysis and their results were compared. Mean fascial defect size was 15.1 cm (range 8.3-22.0). With respect to change in clip distance from Times 1 to 2, three events were observed: (1) Diminished (i.e. medialized), (2) Enlarged, or (3) No Change. Ten patients (83%) medialized, one patient enlarged, and one patient showed no change (chi2 (d.f. = 2) 9.17, p < 0.0023). CONCLUSIONS: Medialization of the rectus abdominus fascia occurs in the majority of patients undergoing LVH repair. Causes for this phenomenon are unclear: however eliminating intrabdominal pressure with intraperitoneal mesh placement likely plays a role.


Asunto(s)
Fascia/diagnóstico por imagen , Hernia Ventral/cirugía , Laparoscopía , Complicaciones Posoperatorias/diagnóstico por imagen , Recto del Abdomen , Adulto , Anciano , Distribución de Chi-Cuadrado , Femenino , Hernia Ventral/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Radiografía , Mallas Quirúrgicas , Resultado del Tratamiento
3.
Eur J Cardiothorac Surg ; 25(6): 925-30, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15144989

RESUMEN

OBJECTIVE: The lack of durable bioprosthetic valves and the inherent risks associated with anticoagulation for mechanical valves have led to the continued use of the Ross procedure, particularly in the pediatric population. METHODS: We have reviewed our mid-term results retrospectively, following the Ross operation in both pediatric and adult groups. RESULTS: Over a 11-year period from August 1991 to August 2002, 60 patients underwent the Ross procedure. The median age was 15 years (6-804 months), of which 63% were males and 55% were under the age of 20 years. The main indications were: aortic stenosis in 47 patients; aortic insufficiency in 6 patients; and mixed aortic valve disease in 28 patients. Fifteen patients had previously undergone balloon dilatation of the aortic valve, 4 had open valvotomy and 3 had both valvuloplasty procedures. The pulmonary autograft was implanted as a sub-coronary implant until 1995 (30%) after which time it was implanted using a partial inclusion cylinder technique (70%). There have been no deaths reported in this series. Over a median follow-up period of 59 months (2-122 months), there have been four re-operations for repair of autograft leak, and 2 adult patients have had autograft replacements. CONCLUSIONS: Despite the increased technical complexity, the Ross procedure can be performed safely in both paediatric and adult populations with satisfactory medium term results.


Asunto(s)
Insuficiencia de la Válvula Aórtica/cirugía , Estenosis de la Válvula Aórtica/cirugía , Implantación de Prótesis de Válvulas Cardíacas/métodos , Válvula Pulmonar/trasplante , Adolescente , Adulto , Anciano , Niño , Preescolar , Femenino , Estudios de Seguimiento , Rechazo de Injerto , Mortalidad Hospitalaria , Humanos , Lactante , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias , Reoperación , Estudios Retrospectivos , Trasplante Autólogo , Resultado del Tratamiento
4.
Mayo Clin Proc ; 76(6): 653-6, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11393506

RESUMEN

Patients with long-standing, severe, erosive rheumatoid arthritis who have extra-articular manifestations and have undergone joint replacement surgery are at increased risk for serious infection and premature mortality. New therapies, including cytokine antagonists, hold great promise for improving the course of rheumatoid arthritis. However, they have powerful anti-inflammatory effects that may mask symptoms of serious infection. We report a case of fatal pneumococcal sepsis occurring in a 37-year-old woman with rheumatoid arthritis treated with the tumor necrosis factor antagonist etanercept and suggest management strategies for early detection and management of this complication.


Asunto(s)
Antirreumáticos/efectos adversos , Artritis Infecciosa/inducido químicamente , Artritis Reumatoide/tratamiento farmacológico , Bacteriemia/inducido químicamente , Fascitis Necrotizante/inducido químicamente , Inmunoglobulina G/efectos adversos , Infecciones Neumocócicas/inducido químicamente , Streptococcus pneumoniae , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Adulto , Antiinflamatorios/uso terapéutico , Artritis Infecciosa/diagnóstico , Artritis Infecciosa/tratamiento farmacológico , Artritis Reumatoide/inmunología , Artritis Reumatoide/cirugía , Bacteriemia/diagnóstico , Bacteriemia/tratamiento farmacológico , Quimioterapia Combinada , Etanercept , Fascitis Necrotizante/diagnóstico , Fascitis Necrotizante/tratamiento farmacológico , Resultado Fatal , Femenino , Humanos , Infecciones Neumocócicas/diagnóstico , Infecciones Neumocócicas/tratamiento farmacológico , Prednisona/uso terapéutico , Receptores del Factor de Necrosis Tumoral , Índice de Severidad de la Enfermedad
5.
Circulation ; 103(6): 842-9, 2001 Feb 13.
Artículo en Inglés | MEDLINE | ID: mdl-11171793

RESUMEN

BACKGROUND: Atrial fibrillation (AF), a cardiac arrhythmia arising from atrial re-entrant circuits, is a common complication after cardiac surgery, but the proarrhythmic substrate underlying the development of postoperative AF remains unclear. This study investigated the hypothesis that altered expression of connexins, the component proteins of gap junctions, is a determinant of a predisposition to AF. METHODS AND RESULTS: The expression of the 3 atrial connexins-connexins 43, 40, and 45-was analyzed at the mRNA and protein levels by Northern and Western blotting techniques and immunoconfocal microscopy in right atrial appendages from patients with ischemic heart disease who were undergoing coronary artery bypass surgery. Twenty percent of the patients subsequently developed AF, which allowed retrospective division of the samples into 2 groups, non-AF and AF. Connexin43 and connexin45 transcript and protein levels did not differ between the groups. However, connexin40 transcript and protein were expressed at significantly higher levels in the AF group. Connexin40 protein was markedly heterogeneous in distribution. CONCLUSIONS: Atrial myocardium susceptible to AF is distinguished from its nonsusceptible counterpart by elevated connexin40 expression. The heterogeneity of connexin distribution could give rise to different resistive properties and conduction velocities in spatially adjacent regions of tissue, which become enhanced and, hence, proarrhythmic the higher the overall level of connexin40.


Asunto(s)
Fibrilación Atrial/metabolismo , Conexinas/análisis , Miocardio/metabolismo , Complicaciones Posoperatorias/metabolismo , Anciano , Anticuerpos/inmunología , Fibrilación Atrial/sangre , Northern Blotting , Western Blotting , Conexina 43/análisis , Conexinas/sangre , Conexinas/inmunología , Puente de Arteria Coronaria , Susceptibilidad a Enfermedades/metabolismo , Endotelio Vascular/metabolismo , Femenino , Técnica del Anticuerpo Fluorescente , Atrios Cardíacos , Humanos , Inmunohistoquímica , Masculino , Microscopía Confocal , Persona de Mediana Edad , Isquemia Miocárdica/cirugía , Complicaciones Posoperatorias/sangre , ARN Mensajero/análisis , Estudios Retrospectivos , Proteína alfa-5 de Unión Comunicante
7.
Invest Ophthalmol Vis Sci ; 36(13): 2592-601, 1995 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7499082

RESUMEN

PURPOSE: The iridocorneal-endothelial (ICE) syndrome is characterized by glaucoma, corneal failure, and iris destruction. Specular photomicroscopy of the corneal endothelium in this disease shows a population of abnormal cells named ICE-cells. Comparison between ultrastructural examination and specular photomicroscopy demonstrates that the histologic equivalent of ICE-cells are cells with an epithelial phenotype. The authors have studied the differentiation markers expressed by ICE-cells using an ultrastructural immunocytochemical technique. METHODS: Seven keratoplasty specimens from patients with the ICE syndrome were examined by scanning and transmission electron microscopy and light and electron microscopic immunocytochemistry. Comparison was made with three normal corneas. Immunocytochemical studies were performed with monoclonal antibodies to broad-spectrum cytokeratins, cytokeratins 3, 5/8, 8/18 and 19, vimentin, and epithelial membrane antigen. RESULTS: ICE-cells were morphologically similar to epithelial cells and expressed the same profile of differentiation markers as did normal limbal epithelial cells. CONCLUSIONS: ICE-cells may arise from an embryologic ectopia of ocular surface epithelium. Alternatively, these findings are consistent with a metaplastic stimulus resulting in a profound change in the phenotype of normal corneal endothelial cells.


Asunto(s)
Enfermedades de la Córnea/patología , Glaucoma/patología , Enfermedades del Iris/patología , Adulto , Córnea/metabolismo , Córnea/patología , Enfermedades de la Córnea/metabolismo , Endotelio Corneal/metabolismo , Endotelio Corneal/patología , Femenino , Glaucoma/metabolismo , Humanos , Inmunohistoquímica , Enfermedades del Iris/metabolismo , Masculino , Microscopía Electrónica , Microscopía Electrónica de Rastreo , Persona de Mediana Edad , Valores de Referencia , Síndrome
8.
J Adolesc Health Care ; 4(2): 113-6, 1983 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-6345494

RESUMEN

This study briefly reviews Gardnerella vaginalis as a primary vaginal pathogen and assesses the efficacy and safety of therapy with a single, 2-g oral dose of metronidazole. Over a period of 20 months, 882 symptomatic adolescent girls had positive cultures for G. vaginalis. All were post-menarcheal. No other vaginal pathogen was isolated in 609. The total group had a second culture 5-7 days after treatment. Cultures taken after treatment were negative in 95% of those treated with a single 2-g dose of metronidazole. Symptoms abated with therapy and culture negativity. Side effects were limited to infrequent, minor gastric distress. Our results suggest the utility of a simplified, one-dose regimen with high efficacy, insignificant side effects, and a lower cost per patient than the current dosage schedule of 500 mg b.i.d. for 7 days.


Asunto(s)
Infecciones por Haemophilus/tratamiento farmacológico , Metronidazol/uso terapéutico , Vaginitis/tratamiento farmacológico , Adolescente , Técnicas Bacteriológicas , Niño , Femenino , Gardnerella vaginalis/efectos de los fármacos , Infecciones por Haemophilus/microbiología , Humanos , Vaginitis/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...